Islamic Medical Association of North America (IMANA) Company Profile

Background

Founded in 1967, the Islamic Medical Association of North America (IMANA) is a non-profit 501(c)(3) organization dedicated to providing a forum and resource for Muslim physicians and other healthcare professionals in the United States and Canada. IMANA's mission is to foster health promotion, disease prevention, and health maintenance in communities worldwide through direct patient care, health programs, and advocacy. The organization emphasizes Islamic medical ethics and values, aiming to positively impact global health through integrated programs, with a significant focus on medical relief efforts.

Key Strategic Focus

IMANA's strategic objectives include:

• Medical Relief: Through IMANA Medical Relief (IMR), the organization responds to disasters, provides basic healthcare to underserved communities, and develops programs for knowledge transfer. IMR has conducted missions in over 30 countries, treating more than 2.5 million patients.

• Continuing Medical Education (CME): IMANA is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer CME activities, including courses, conferences, and workshops, reinforcing its commitment to optimizing patient care.

• Mentorship and Scholarships: The organization provides mentorship programs for medical students and offers scholarships to full-time students pursuing careers in medicine, pharmacy, dentistry, and allied health fields.

Financials and Funding

As of the fiscal year ending December 2023, IMANA reported:

• Revenue: $2,874,345

• Expenses: $2,693,656

• Net Income: $180,689

• Net Assets: $7,411,092

The majority of revenue (98.2%) was derived from contributions, with investment income accounting for 1.4%. Program expenses constituted 64.2% of total expenses.

Leadership Team

IMANA's leadership comprises dedicated professionals committed to advancing the organization's mission:

• Marium Husain, MD, MPH: President

• Nida Saleem: Executive Director

• Fariha Khan, MD: Director

• Tariq H. Cheema, MD: Director

• Ismail Mehr, MD: IMR Chair

Notably, the executive director received compensation of $149,262, while other key personnel served without compensation.

Leadership Changes

In October 2021, IMANA expanded its footprint by opening a permanent office in Fairfax, Virginia, to build strategic partnerships in the Washington, D.C., area. This expansion was led by Executive Director Akrama Hashmi, emphasizing the organization's commitment to providing compassionate care and strengthening relationships with local organizations.

Competitor Profile

Market Insights and Dynamics

The global halal pharmaceuticals market is experiencing significant growth, driven by increasing demand for products compliant with Islamic dietary laws. The market is projected to reach USD 205.30 billion by 2034, growing at a CAGR of 24.39% from 2025 to 2034. This growth is attributed to the rising Muslim population, heightened health consciousness, and supportive government regulations promoting halal certification.

Competitor Analysis

Key players in the halal pharmaceuticals market include:

• CCM Pharmaceuticals: Specializes in halal-certified over-the-counter drugs and health supplements.

• Pharmaniaga Berhad: A leading Malaysian pharmaceutical company offering a range of halal-certified products.

• Chemical Company of Malaysia Berhad (CCM): Provides halal pharmaceuticals and healthcare products.

These companies focus on developing and marketing halal-certified pharmaceuticals to cater to the growing demand among Muslim consumers.

Strategic Collaborations and Partnerships

IMANA collaborates with various organizations to enhance its impact:

• Scheherazade Foundation: Partnered to deliver medical supplies valued at over $15 million to Ukraine via Romania, demonstrating IMANA's commitment to global humanitarian efforts.

• ADAMS Center: Established partnerships in the Washington, D.C., area to strengthen community health initiatives.

Operational Insights

IMANA's strategic positioning in the halal pharmaceuticals market is bolstered by its:

• Accreditation: As an ACCME-accredited provider, IMANA offers CME activities, enhancing the professional development of healthcare providers.

• Global Reach: Through IMR, the organization has conducted medical missions in over 30 countries, treating millions of patients and establishing a strong international presence.

• Community Engagement: IMANA's mentorship and scholarship programs support the next generation of healthcare professionals, fostering a network of skilled practitioners committed to ethical medical practices.

Strategic Opportunities and Future Directions

IMANA is poised to leverage the growing demand for halal-certified pharmaceuticals by:

• Expanding Educational Programs: Enhancing CME offerings to address emerging health challenges and promote best practices in halal pharmaceuticals.

• Strengthening Partnerships: Building alliances with pharmaceutical companies to develop and distribute halal-certified medications.

• Advocacy and Policy Engagement: Collaborating with policymakers to establish and promote standards for halal pharmaceuticals, ensuring compliance and consumer trust.

Contact Information

For more information about IMANA and its initiatives, please visit their official website.

IMANA's headquarters are located in Lombard, Illinois, with an additional office in Fairfax, Virginia.